SCHEMBL7709012

SCHEMBL7709012

Nc1cc(-c2cccc(C(F)(F)F)c2)cc2nc(-c3cccs3)nn12

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 1/20 0.49
ALDH1A1 P00352 6/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
HPGD P15428 2/20 0.46
MEN1 O00255 1/20 0.46
KMT2A Q03164 1/20 0.46
KDM4E B2RXH2 6/20 0.44
RXFP1 Q9HBX9 1/20 0.44
LRRK2 Q5S007 4/20 0.43
FUBP1 Q96AE4 2/20 0.42
GAA P10253 2/20 0.42
LMNA P02545 1/20 0.42
GLA P06280 1/20 0.42
DYRK1A Q13627 2/20 0.40
DYRK2 Q92630 2/20 0.40
CCNA2 P20248 1/20 0.40
CDK2 P24941 1/20 0.40
CDK5 Q00535 1/20 0.40
CDK5R1 Q15078 1/20 0.40
DYRK1B Q9Y463 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7709150 0.85 ADORA2A (0.54) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7708740 0.84 ADORA2A (0.57) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7708573 0.83 ADORA2A (0.52) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7708503 0.80 NPC1 (0.53) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7432234 0.80 ADORA2A (0.56) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7705947 0.78 ADORA2A (0.54) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7481723 0.78 ADORA2A (0.53) ADORA2A
SCHEMBL7705888 0.78 ADORA2A (0.49) ADORA2AALDH1A1L3MBTL1HPGDMEN1
SCHEMBL7711758 0.77 ADORA2A (0.50) ADORA2AALDH1A1HPGDKDM4EHTT
SCHEMBL7703024 0.77 ADORA2A (0.49) ADORA2AALDH1A1HPGDKDM4ECYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6355653-B1 DRUG AND CARRIER FOR ANTIALLERGENS, BRAIN DISORDERS AND NEUROTRANSMITTERS HOFFMANN-LA ROCHE INC. 2002-03-12 US disclosed